Context Therapeutics Inc.(CNTX)

Biotechnology · Philadelphia, PA

$0.34+0.01 (+2.17%)

Delayed quote: Oct 6, 2026, 11:40 AM EDT

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T15:41:25.433Z.

Stored calculation inputs

Calculation as of: 2026-10-06T15:41:25.433Z.

Quote observation: 2026-10-06T15:40:16.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 0.3438
Unrounded diluted TTM EPS · period ending 2026-06-30: -0.4812

FMP input reference: c88c4f39e0f2b8ce509c05ad310ef4a925915372bb385716b1b31bbca6f45484

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

CNTX PE Ratio Metrics

PE RATIO

N/A

CNTX Competitors' PE Ratio

CNTX

Context Therapeutics Inc.

Current

Market Cap

$31.59M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BDMD

Baird Medical Investment Holdings Limited

vs CNTX

Market Cap

$31.23M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NSYS

Nortech Systems Incorporated

vs CNTX

Market Cap

$31.77M

PE Ratio

30.91

TTM Avg

37.13

3Y Avg

14.27

5Y Avg

11.10

MIRA

MIRA Pharmaceuticals, Inc.

vs CNTX

Market Cap

$31.37M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MDXH

MDxHealth S.A.

vs CNTX

Market Cap

$30.96M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BYSI

BeyondSpring Inc.

vs CNTX

Market Cap

$31.26M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EUDA

EUDA Health Holdings Limited

vs CNTX

Market Cap

$32.76M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BEAT

HeartBeam, Inc.

vs CNTX

Market Cap

$32.75M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GRDX

GridAI Technologies Corp.

vs CNTX

Market Cap

$30.27M

PE Ratio

N/A

TTM Avg

0.40

3Y Avg

0.40

5Y Avg

0.40

ALGS

Aligos Therapeutics, Inc.

vs CNTX

Market Cap

$33.66M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Context Therapeutics Inc. (CNTX)	$31.59M	N/A	N/A	N/A	N/A
Baird Medical Investment Holdings Limited (BDMD)vs ›	$31.23M	N/A	N/A	N/A	N/A
Nortech Systems Incorporated (NSYS)vs ›	$31.77M	30.91	37.13	14.27	11.10
MIRA Pharmaceuticals, Inc. (MIRA)vs ›	$31.37M	N/A	N/A	N/A	N/A
MDxHealth S.A. (MDXH)vs ›	$30.96M	N/A	N/A	N/A	N/A
BeyondSpring Inc. (BYSI)vs ›	$31.26M	N/A	N/A	N/A	N/A
EUDA Health Holdings Limited (EUDA)vs ›	$32.76M	N/A	N/A	N/A	N/A
HeartBeam, Inc. (BEAT)vs ›	$32.75M	N/A	N/A	N/A	N/A
GridAI Technologies Corp. (GRDX)vs ›	$30.27M	N/A	0.40	0.40	0.40
Aligos Therapeutics, Inc. (ALGS)vs ›	$33.66M	N/A	N/A	N/A	N/A

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$0.34

Forward EPS (Est.)

$-0.46

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

CNTX PE Ratio Metrics

CNTX Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics